(Q45151263)

10 December 2017

title

Study of patients referred for elevated ferritin levels and/or transferrin saturation: significance of non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

10 December 2017

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

2

1 reference

10 December 2017

F Pérez-Aguilar

1

1 reference

10 December 2017

M Berenguer

series ordinal

3

1 reference

10 December 2017

publication date

1 November 2004

1 reference

Gastroenterología y Hepatología

10 December 2017

published in

1 reference

10 December 2017

volume

27

1 reference

10 December 2017

issue

9

1 reference

10 December 2017

page(s)

508-514

1 reference

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Hepatic iron and nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Insulin resistance-associated hepatic iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

A new syndrome of liver iron overload with normal transferrin saturation.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Molecular medicine and hemochromatosis: at the crossroads

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

[Hereditary hemochromatosis: physiopathological, clinical and therapeutical considerations]

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Nonalcoholic steatohepatitis: definition and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Metformin in non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Serum ferritin as a component of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Venesection therapy of insulin resistance-associated hepatic iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Metformin reverses fatty liver disease in obese, leptin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970517-2

7 January 2021

10.1016/S0210-5705(03)70517-2

Identifiers

DOI

1 reference

10 December 2017

1 reference